ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M

ADMA Biologics reports 2020 executive compensation

By ExecPay News

Published: April 7, 2021

ADMA Biologics reported fiscal year 2020 executive compensation information on April 7, 2021.
In 2020, three executives at ADMA Biologics received on average a compensation package of $1.4M, a 5% increase compared to previous year.
Average pay of disclosed executives at ADMA Biologics
Adam S. Grossman, Chief Executive Officer, received $2M in total, which increased by 15% compared to 2019. 31% of Grossman's compensation, or $600K, was in salary. Grossman also received $486K in bonus, $545K in option awards, $292K in stock awards, as well as $40K in other compensation.
James Mond, Chief Scientific Officer, received a compensation package of $1.2M, which decreased by 3% compared to previous year. 37% of the compensation package, or $440K, was in salary.
Brian Lenz, Chief Financial Officer, earned $1.1M in 2020, a 3% decrease compared to previous year.

Related executives

Adam Grossman

ADMA Biologics

Chief Executive Officer

James Mond

ADMA Biologics

Chief Scientific Officer

Brian Lenz

ADMA Biologics

Chief Financial Officer

You may also like

Source: SEC filing on April 7, 2021.